Despite strong revenue, the high P/S ratio suggests potentia...
Despite strong revenue, the high P/S ratio suggests potential overvaluation. Investors' bullishness may lead to disappointment if P/S aligns with growth outlook. The share price risks decline due to mediocre revenue forecasts.
Ocular Therapeutix, Inc.'s (NASDAQ:OCUL) Shares Climb 111% But Its Business Is Yet to Catch Up
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment